Clinical Trials Browser

Interventional × Salivary Gland Neoplasms × MK 2206 × Clear all

NCT01604772 2019-05-01

Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma

Phase 2 Completed

16 enrolled 7 charts

Salivary Gland Neoplasms